Explore the Top 10 Medical Device Trends in 2026

Executive Summary: What are the Top 10 Medical Device Trends in 2026 & Beyond?

1. Sustainability & Circularity: The NHS Net Zero Supplier Roadmap requires supplier carbon-reduction plans and ongoing disclosures. A 2019 study found that 62% of NHS emissions come from its supply chain.
2. Machine Learning & Gen AI: All 43 US health systems in a 2024 survey were piloting or deploying gen AI, with 53% reporting strong results for documentation. Moreover, the FDA has now listed 1016 AI/ML-enabled devices as of July 2025.
3. Cybersecurity: IBM’s 2025 study puts the average healthcare breach at USD 7.42 million with an average 279-day detection/containment window. Consequently, the medical device cybersecurity solutions market is expected to reach USD 41.25 billion by 2029.
4. Medical Robots: Precedence Research estimates that the medical robots market will reach USD 64.36 billion by 2034 at a 17.11% CAGR. Innovations include Intuitive’s da Vinci 5 and Johnson & Johnson’s first clinical trial with OTTAVA.
5. Wearable Devices: The FDA cleared the first over-the-counter continuous glucose monitor (CGM), Dexcom Stelo. A 2025 US survey found 36% of adults used a healthcare wearable in the past year, while broader wearables shipments climbed to 534 million units in 2024.
6. Internet of Medical Things (IoMT): Surveys indicate 85% of healthcare providers already use IoMT for patient engagement, remote monitoring, or smart-facility use cases. The IoMT market is projected to grow at a 18.2% CAGR to reach USD 658.57 billion by 2030.
7. 3D Printing: Last year, the FDA cleared the first 3D-printed PEEK cranial implant system (3D Systems’ VSP PEEK). Vendors like Materialise and Ricoh also launched dedicated additive manufacturing programs this year.
8. Point-of-Care (PoC) & Handheld Diagnostics: Regulatory momentum is accelerating access for PoC and handheld medical devices. In October 2024, the FDA authorized the first OTC combo flu/COVID-19 rapid antigen home test outside EUA. The POC diagnostics market is expected to reach USD 68.5 billion by 2030 (5.8% CAGR).
9. Brain-Computer Interfaces (BCIs) & Neurotechnology: NIH and UC Berkeley highlight works in near-real-time, audible speech synthesis from brain signals in 2025. More than 300 000 deep-brain-stimulation (DBS) systems have been implanted worldwide.
10. Hospital-at-Home & Home-based Care: According to an American Hospital Association fact sheet, 400 hospitals across 142 systems in 39 states in the US were approved for HaH by July 2025. CMS’s 2024 study also found that HaH patients generally had lower mortality, lower hospital-acquired conditions, and mixed but competitive 30-day readmissions.

Read on to explore each trend in depth – uncover key drivers, current market stats, cutting-edge innovations, and 20 leading innovators shaping the future.

Frequently Asked Questions

1. What is the latest medical device technology?

Eko Health developed an AI-driven digital stethoscope in collaboration with Imperial College London. It detects heart conditions like heart failure, valve disease, and atrial fibrillation in just 15 seconds. It also records heart sounds and an ECG, analyzes them via AI, and returns rapid results to a smartphone.

2. What is the fastest-growing medical device market?

The fastest-growing medical device market segment is the pulsed-field ablation (PFA) devices. This segment is projected to experience a CAGR of 80.7% between 2023 and 2028, making it the standout leader in market expansion.

3. Who is the largest company in medical devices?

The largest medical device company by revenue is Medtronic. It reclaimed its spot as the global leader last year, with annual revenues of approximately USD 32.4 billion.

Methodology: How We Created the Medical Device Trend Report

For our trend reports, we leverage our proprietary StartUs Insights Discovery Platform, covering 7M+ global startups, 20K technologies & trends, plus 150M+ patents, news articles, and market reports.

Creating a report involves approximately 40 hours of analysis. We evaluate our own startup data and complement these insights with external research, including industry reports, news articles, and market analyses. This process enables us to identify the most impactful and innovative trends in the medical device industry.

For each trend, we select two exemplary startups that meet the following criteria:

• Relevance: Their product, technology, or solution aligns with the trend.
• Founding Year: Established between 2020 and 2025.
• Company Size: A maximum of 200 employees.
• Location: Specific geographic considerations.

This approach ensures our reports provide reliable, actionable insights into the medical device innovation ecosystem while highlighting startups driving technological advancements in the industry.

Innovation Map outlines the Top 10 Medical Device Trends & 20 Promising Startups

For this in-depth research on the Top Medical Device Trends & Startups, we analyzed a sample of 4000+ global startups & scaleups. The Medical Device Innovation Map created from this data-driven research helps you improve strategic decision-making by giving you a comprehensive overview of the medical device industry trends & startups that impact your company.

Tree Map reveals the Impact of the Top 10 Medical Device Trends in 2026

The Medical Device Tree Map highlights the Top 10 Medical Device Trends. Startups and scaleups are developing wearable and IoMT solutions for personalized healthcare. Automation drives the adoption of medical robotics, AI, and immersive technologies in the medical device sector.

Startups are also creating minimally invasive devices for procedural challenges and patient safety. They leverage 3D printing for rapid prototyping. Medical device manufacturers are transitioning to more responsible operations through medical waste management.

Global Startup Heat Map covers 4063 Medical Device Startups & Scaleups

The Global Startup Heat Map showcases the distribution of 4063 exemplary startups and scaleups analyzed using the StartUs Insights Discovery Platform. It highlights high startup activity in the United States and Europe, followed by India. From these, 20 promising startups are featured below, selected based on factors like founding year, location, and funding.

Want to Explore Medical Device Innovations & Trends?

Top 10 Medical Device Trends in 2026

1. Sustainability & Circularity: 60% NHS Emissions Come from the Supply Chain

The NHS Net Zero Supplier Roadmap requires supplier carbon-reduction plans and ongoing disclosures. A 2019 study found that 62% of NHS emissions come from its supply chain.

According to a 2019 study, reprocessing of single-use devices (SUDs) removed 15 million pounds of medical waste, but researchers say hospitals are reprocessing only a small portion of what could be done.

AMDR reports that hospitals saved USD 451 million by reprocessing devices in 2024. This means that circular practices can reduce footprint and cost without sacrificing performance.

The EU’s MDR Article 17 continues to enable SUD reprocessing under national law, reinforcing safety and accountability.

Sterilization is also being decarbonized. For example, the US EPA’s March 2024 rule compels 90% cuts in ethylene oxide (EtO) emissions from commercial sterilizers even as the FDA notes roughly 50% of US sterile devices rely on EtO.

Packaging and end-of-life rules are also tightening in Europe. The EU Packaging Regulation requires recyclable, right-sized packaging, and clearer labelling with limited exemptions for contact-sensitive packs.

Philips targets 25% of revenue from circular offerings and reports a refurbished Azurion 7 C20 interventional system cut lifetime CO2 by 28% versus a new product. GE HealthCare also details large-scale recovery/refurbishment through GoldSeal and other programs.

Porrima Technologies manufactures Biodegradable Single-Use Plastics

Porrima Technologies is a Canadian company that makes biodegradable single-use plastics for labs. Its products include Petri dishes, Eppendorf tubes, and pipette tips. The startup converts agricultural waste into bioplastics to make its products.

By using the startup’s products, healthcare institutions are able to better manage medical waste as the products break down more easily than traditional plastics. This leads to more sustainable operations.

SymbioTex offers Compostable Bioplastics

SymbioTex is a UK-based startup that develops compostable bioplastics from seaweed to make medical disposables. The startup converts farmed seaweed into rigid, injection-moldable pellets.

The pellets substitute traditional plastics and eliminate the need for industrial composting.

2. Machine Learning & Generative AI

AI-enabled medical devices analyze multimodal patient data like images, waveforms, notes, and genomics. This enables healthcare professionals to detect disease earlier, predict deterioration, and track therapy response in real time.

Generative AI adds new capabilities like auto-drafting reports and patient summaries, as well as creating high-fidelity synthetic data for rare conditions.

For instance, all 43 US health systems in a 2024 survey were piloting or deploying gen AI, with 53% reporting strong results for documentation.

On the supply side, the FDA has now listed 1016 AI/ML-enabled devices as of July 2025.

Further, the FDA finalized the Predetermined Change Control Plan for AI-enabled device software functions in August 2025. It explicitly enables safer, iterative model updates, and the agency is preparing to tag devices that use foundation models/LLMs.

In the EU, AI used within medical device regulations (MDR) and in vitro diagnostic medical devices regulation (IVDR) is generally treated as high-risk. This tightens obligations without changing the device risk class.

Beyond clinical features (like computer vision for triage and guidance, AI-assisted robotics), manufacturers are deploying ML and generative AI to optimize production yield, quality assurance (QA), and service.

The broader AI market in medical devices is projected to reach about USD 35.5 billion by 2029 at a 29.9% CAGR.

Nightingale provides a Smart Wristband

Taiwanese startup Nightingale offers an infection prediction smart wristband. The AI-enabled wearable device, HEARThermo, continuously monitors the changes in body temperature and heart rate.

HEARThermo‘s AI generates an analysis report that allows healthcare providers to predict infections. This allows public health workers to monitor suspected cases during an infectious outbreak.

PneumoWave develops a Smart Biosensor

UK-based startup PneumoWave devises a chest-worn smart biosensor. The biosensor captures respiratory data, and the startup’s platform analyses it using machine learning algorithms.

This improves the monitoring of chronic obstructive pulmonary disease (COPD). It detects early signs of deterioration and notifies the patients and physicians. This allows rapid treatment and reduces or shortens hospital admissions.

3. Cybersecurity Innovations

In the US, HHS confirmed that the 2024 Change Healthcare ransomware attack affected 192.7 million people. This underscores systemic exposure across clinical networks and supply chains.

Healthcare also continues to face the highest breach costs. IBM’s 2025 study puts the average healthcare breach at USD 7.42 million with an average 279-day detection/containment window.

Security innovation is accelerating to meet this threat. Device makers and providers deploy IoMT asset discovery, zero-trust segmentation, signed firmware/secure boot, and continuous vulnerability scanning.

Other technologies include software bill of materials (SBOM)-driven vulnerability management, coordinated vulnerability disclosure (CVD), and AI-assisted anomaly detection.

Further, policy is shaping roadmaps to strengthen cybersecurity in medical devices.

For instance, the FDA’s final June 2025 guidance supersedes 2023 and cements expectations for threat modeling and update/patch plans, and Section 524B requirements for cyber devices. This includes ongoing monitoring, SBOMs, and coordinated disclosure.

Simultaneously, the US HPH Cybersecurity Performance Goals (essential + enhanced controls) steer hospitals toward MFA, asset inventories, segmentation, and tested IR plans.

Europe’s NIS2 further puts healthcare in scope with tight incident-reporting clocks – 24h early warning, 72h initial notification, and a one-month final report. This raises the bar for providers and suppliers alike.

Consequently, market researchers expect the medical device cybersecurity solutions market to reach USD 16.67 billion by 2025, and USD 41.25 billion by 2029 at a 23.9% CAGR.

Culinda simplifies Medical Device Security Management

US-based startup Culinda offers end-to-end medical device security management. It uses AI to prevent medical devices from cyberattacks by enabling real-time defenses.

Further, the startup uses blockchain to provide continuous access to device information such as communication sources, device inventory mapping, etc. Culinda’s solution allows hospitals to securely manage all medical assets.

PROREGIA develops End-to-End Framework Modules for Connected Medical Devices

PROREGIA is a Swiss startup that specializes in cybersecurity for connected medical devices. Their modules facilitate the integration into the IoMT, emphasizing security separation from business logic.

The startup’s end-to-end modules focus on device-specific cryptographic operations, ensuring attacks don’t scale. Its asset management feature tracks devices, preventing counterfeiting and offering insights into device metrics.

Over-the-air firmware updates enhance device usability, monitored by asset management. PROREGIA’s 3rd-party interaction framework ensures secure, traceable interactions for medical devices. Their app authentication solution defends against phishing, ensuring devices communicate only with official apps.

4. Medical Robots

In soft-tissue surgery, Intuitive’s fifth-generation da Vinci 5 is now cleared in the US and entered Europe in mid-2025. The company installed 395 systems in Q2 2025 for Intuitive Surgical (including 180 da Vinci 5 units) and guided 17% procedure growth for 2025

Intuitive also publicly demonstrated long-distance telesurgery hand-offs on a da Vinci 5 in July 2025.

Likewise, Johnson & Johnson completed the first clinical trial cases with its OTTAVA soft-tissue robot in April 2025. Medtronic’s HUGO also met safety/effectiveness endpoints in a US trial and was submitted to the FDA in Q1 2025.

In orthopedics, Stryker’s Mako crossed 2 million cumulative robotic procedures by Q2 2025, and Zimmer Biomet’s ROSA platform is approaching 2000 installations while adding new indications.

Beyond the OR, robotic innovation is expanding in cardiology and hospital operations.

Endovascular/percutaneous coronary intervention (PCI) robotics (like Siemens Healthineers’ Corindus CorPath GRX) continued to show favorable safety in 2025 studies. They are also adding smart-automation features, laying the groundwork for greater precision and potential remote operation.

Hospitals are also deploying UV-C disinfection robots and autonomous delivery systems. For example, the Cleveland Clinic has planned to launch a drone prescription delivery service in 2025.

The commercial outlook reflects this surge. Precedence Research estimates that the medical robots market will reach USD 64.36 billion by 2034 at a 17.11% CAGR.

RIF Robotics automates Surgical Tray Preparation

US startup RIF Robotics creates a robotic system that automates surgical tray preparation. This system uses computer vision and robotics to identify, inspect, and handle surgical instruments.

It improves sterile processing productivity and reduces preparation errors, which prevents operating room delays and patient infections. The startup makes the instrument reprocessing pipeline smarter to ensure hospitals have a steady supply of clean and functional surgical instruments.

Theranautilus provides Oral Healthcare Nanobots

Indian startup Theranautilus provides oral healthcare nanobots. The startup’s magnetic bots, BIO BOTS, feature lacings of bioactive components that are capable of reaching the dentinal tissues.

It permanently treats tooth hypersensitivity and promotes tooth regeneration. Dentists leverage the startup’s bots to automate intelligent targeting of drugs for oral diseases.

Further, Theranautilus secured USD 1.2 million in funding led by Pi Ventures.

5. Wearable Medical Devices

Clinical-grade biosensors feed continuous vitals (glucose, SpO2, temperature, sleep) into care pathways for earlier detection, remote monitoring, and faster interventions.

The market is projected to reach USD 168.29 billion by 2030 at a 25.53% CAGR.

Regulations and product approvals are accelerating adoption.

In 2024, the FDA cleared the first over-the-counter continuous glucose monitor (CGM), Dexcom Stelo, and two OTC Abbott systems, Libre Rio and Lingo. They expand glucose tracking to non-insulin users and wellness use cases.

Further, Google’s Pixel Watch 3 won FDA clearance for Loss of Pulse Detection. This safety feature auto-initiates an emergency call when the watch detects pulselessness. This illustrates how consumer wearables are crossing into medical functions.

The FDA also published an updated list of sensor-based digital health technology (sDHT) devices in July 2025 that span smartwatches, rings, patches, and bands. This signals a broad and growing pipeline of approved wearables.

On the outcome side, long-wear ECG patches pair FDA-cleared AI with multi-day recordings to improve arrhythmia detection. This supports cardiology and virtual-care workflows.

A 2025 US survey found 36% of adults used a healthcare wearable in the past year, while broader wearables shipments climbed to 534 million units in 2024.

This data shows that the adoption of medical wearables is rising for remote patient monitoring (RPM) and hospital-at-home programs.

Together, these advances allow clinicians to deliver more proactive, personalized care while enabling patients to leverage continuous, non-invasive monitoring that shortens time-to-diagnosis and improves outcomes.

Aidmed develops a Chest-worn Portable Device

Polish startup Aidmed develops a chest-worn portable device. The startup’s wearable recorder, Aidmed One, uses biosensors to record physiological parameters like blood pressure, temperature, and electrocardiogram (ECG). It then uses AI to turn this data into actionable insights into patient conditions.

Gate Science offers a Pain-controlling Wearable

US-based startup Gate Science offers a pain-controlling wearable device. The startup’s product, RELAY, combines pharmacologic blockade and neuromodulation capabilities in a single multimodal device.

Further, Gate Science’s companion app allows patients to control these signaling mechanisms. The startup’s solution offers doctors and patients an alternative to post-surgery pain-killing narcotics.

6. Internet of Medical Things: Smart Implants & Instruments

IoT-enabled remote care and hospital operations link in-home and on-body sensors to electronic health records (EHRs) and clinical dashboards. This enables continuous vitals monitoring, asset tracking, and closed-loop workflows.

The IoMT market is projected to grow at a 18.2% CAGR to reach USD 658.57 billion by 2030. This reflects rapid deployment across providers.

Further, surveys indicate 85% of healthcare providers already use IoMT for patient engagement, remote monitoring, or smart-facility use cases.

Inside hospitals, there are 10-15 connected medical devices per bed. Consequently, this drives demand for zero-trust networking, segmentation, and secure-by-design devices.

RPM and hospital-at-home programs show measurable impact. Medicare RPM spend jumped from USD 15 million in 2019 to USD 300 million in 2022.

Further, over 350 US hospitals offer hospital-at-home services, and a 2025 study at Michigan Medicine reported 59% fewer hospitalizations after RPM enrollment.

At the same time, infrastructure upgrades (like Wi-Fi 6/7, 5G, and 6G pilots) are enabling higher device density and lower-latency data flows for bedside monitoring and training. 6G research points to even tighter, more secure IoMT integration.

Orbicor Technologies offers a Cardiovascular Management Platform

Costa Rican startup Orbicor Technologies builds UnnoMed, a cardiovascular management platform. The platform provides differentiated clinical data using IoMT medical devices.

This data is complementary to what is already available to cardiovascular patients and enables ongoing control and optimizes the treatment of their conditions. This way, the platform supports healthcare providers in detecting the early stage and evolution of cardiovascular diseases (CVD).

EloCare creates a Connected Menopause Care Device

Singaporean startup EloCare develops a connected menopause care device. The startup’s wearable, Elo, continuously monitors symptoms and collects data on health parameters.

Clinicians utilize the data to create personalized health profiles. This improves the delivery of lifestyle or medical intervention for women undergoing menopause.

7. 3D Printing

Additive manufacturing enables healthcare institutions to embed patient-specific implants, surgical guides, and point-of-care labs \in care pathways.

Last year, the FDA cleared the first 3D-printed PEEK cranial implant system (3D Systems’ VSP PEEK), and 2025 has seen continued momentum in orthopedics. For example, the new 3D-printed tibial baseplates and pedicle screw systems.

These products underscore broader clinical acceptance of lattice and porous designs for osseointegration.

Dental remains the highest-volume application for 3D-printed parts. Align Technology now produces more than 1 million appliances (including aligner parts) per day, while 3D Systems targets direct-printed aligners by late 2025.

Moreover, hospitals are expanding PoC 3D printing to speed surgical planning and patient-matched devices. Vendors like Materialise and Ricoh launched dedicated programs this year. They allow hospitals to integrate compliant labs with streamlined software and services.

As the market penetration for 3D printing increases, regulations and standards are also maturing. The FDA’s Technical Considerations for Additive Manufactured Medical Devices remains the core guidance, while CDRH’s FY2025 agenda flags forthcoming PoC policy, and U.S. reimbursement infrastructure is inching forward.

Quality frameworks like ISO/ASTM 52920:2023 and ASTM F42’s medical standards are also increasingly referenced by manufacturers and auditors. This approach improves consistency and accelerates scale-up.

Market outlooks vary by analyst, but all point to sustained double-digit growth. For example, Precedence Research forecasts the healthcare AM market to grow at a 21.7% CAGR to reach USD 78.06 billion by 2034.

VisionAir Solutions creates 3D-printed Silicone Stents

US-based startup VisionAir Solutions creates 3D-printed silicone stents. The startup’s production process combines 3D printing with traditional medical-grade silicone injection.

The startup’s stents help patients with central airway obstructions breathe easier. Its cloud-based platform enables treating pulmonologists to design these stents specifically for each patient.

Spectroplast manufactures 3D-printed Biocompatible Devices

Swiss startup Spectroplast offers silicon-based biocompatible devices. The startup’s 3D printing technology enables the direct fabrication of pure silicones without the use of molds.

Medical device manufacturers leverage this silicon additive manufacturing (SAM) technology to save costs and develop on-demand production capabilities. It facilitates the production of anatomical devices, implants, and orthotics, among other devices.

Further, Spectroplast completed its Series A financing round, led by HZG Group.

8. PoC & Handheld Diagnostics

Globally, the POC diagnostics market is expected to reach USD 68.5 billion by 2030 (5.8% CAGR). Handheld ultrasound – now common in primary care and emergency medical services (EMS).

Additionally, regulatory momentum is accelerating access for PoC and handheld medical devices. In October 2024, the FDA authorized the first OTC combo flu/COVID-19 rapid antigen home test outside EUA.

Further, the FDA granted marketing authorization to the first fully at-home molecular test for chlamydia, gonorrhea, and trichomoniasis (results ~30 minutes) in Mar 2025.

At the professional PoC level, CLIA-waived offerings continue to expand. CMS added new waived molecular codes in 2024-2025, and the FDA posts ongoing CLIA Waiver by Application decisions.

Additionally, rapid isothermal NAAT platforms deliver molecular results in minutes at the point of care.

The field is moving into microfluidic lab-on-a-chip and CRISPR-based assays that couple isothermal amplification with simple, integrated workflows suited for near-patient or at-home use.

Recent reviews in 2025 highlight advances in automation, one-pot formats, and single-nucleotide specificity. They raise sensitivity and broaden use cases across infectious disease, oncology, and genetics.

Satio offers Patch-based Diagnostics

US-based startup Satio provides painless, patch-based diagnostics and drug delivery at home. The startup’s blood collection and diagnostic device, SatioDx, draws blood using a vacuum. It features lateral flow assays and biosensors for multiplex testing.

SatioRx, its motor-controlled, intradermal/subcutaneous drug delivery patch, utilizes microneedles, an adhesive disposable, and a reusable applicator. It supports controlled dosing, remote controllable delivery, and patient vitals monitoring.

These products are more affordable and easier to use than conventional blood draws, as well as decentralize diagnosis and medication administration.

EveryBaby improves Maternal and Neonatal Care

EveryBaby is an Irish startup that develops a handheld device to assess cervical health. It utilizes electrical impedance spectroscopy (EIS) to offer preterm birth diagnostics. This allows healthcare providers to ensure early interventions even in asymptomatic, low-risk pregnancies.

9. Brain-Computer Interfaces & Neurotechnology

Neuralink‘s first human implant enabled a patient with quadriplegia to control a cursor and apps by thought. With expanded updates through 2025, additional participants were implanted.

Further, Synchron’s endovascular Stentrode met safety and feasibility goals in the US COMMAND trial – first FDA-approved permanently implanted BCI study. It had accurate deployment in 100% of patients and reliable digital task control.

Precision Neuroscience also earned FDA 510(k) clearance this year for its high-resolution Layer 7 Cortical Interface. It was authorized for up to 30 days of implantation to map and stimulate cortical activity. This marks a significant regulatory foothold for clinical BCI components.

Moreover, communication BCIs are leaping ahead. NIH and UC Berkeley highlight works in near-real-time, audible speech synthesis from brain signals in 2025. This points to naturalistic voice restoration for people with paralysis.

Simultaneously, mainstream neurotech keeps scaling. More than 300 000 deep-brain-stimulation (DBS) systems have been implanted worldwide.

Closed-loop spinal cord stimulation (SCS) shows sustained superiority at 36 months versus open-loop in randomized trials. This is evidence that adaptive, feedback-driven neurostimulation is becoming standard care.

The FDA’s BCI guidance for BCIs defines non-clinical and clinical expectations for implanted BCIs. At the same time, Colorado now explicitly protects neural data under privacy law – part of a broader neurorights push as consumer and medical neurotech converge.

Neuhera develops a Brain Health Platform

Neuhera is a Spanish startup that builds a brain health platform using BCI, virtual reality (VR), and AI to improve cognitive therapies and self-enhancement.

The BCI utilizes multi-sensor EEG systems to track neural activity in real time and dynamically adapt therapy intensity and feedback. Simultaneously, VR offers customized, engaging environments and AI monitors physiological and behavioral indicators.

Consequently, the platform fine-tunes therapy experiences continuously to deliver a highly personalized regimen. This reduces stress, elevates motivation, and sharpens concentration.

NeuroBrave provides Spectral Analysis

NeuroBrave is an Israeli company that offers a non-invasive, real-time EEG spectral analysis solution. It utilizes 4 conductive fabric contact points to offer insights.

The startup’s NeuroSpeed OS is a generic software solution that provides real-time cognitive states and neuromarker insights as a service. It is hardware agnostic and connects to most sensors and devices.

These features allow R&D teams to leverage a real-time online streaming pipeline, advanced signal processing, a deep dive into data, and more. Medical device companies are also able to shorten time to market and mitigate expensive in-house software development.

10. Hospital-at-Home & Home-Based Care

Hospital-at-Home and broader home-based care are shifting acute and post-acute services into the living room. They are powered by remote monitoring, PoC testing, and home-ready devices.

According to an American Hospital Association fact sheet, 400 hospitals across 142 systems in 39 states in the US were approved for HaH by July 2025.

Moreover, the outcomes are encouraging. CMS’s 2024 study found HaH patients generally had lower mortality, lower hospital-acquired conditions, and mixed but competitive 30-day readmissions.

They also had lower 30-day post-discharge Medicare spending across more than half of the top diagnosis-related groups (DRGs).

FDA-cleared multi-patient wearables, like BioIntelliSense BioButton, scale virtual-ward operations from hospital to home.

Financing signals momentum, too – Medicare payments for remote patient monitoring topped USD 500 million in 2024 (vs. USD 311 million in 2022). This underscores the rapid integration of connected devices into home-based care.

HaH & home-based care are also becoming a core channel for medtech. Companies design for safe unattended use, plug-and-play connectivity, battery-first portability, and streamlined logistics. Hospitals are able to deliver inpatient-level care at home with evidence-backed outcomes.

Medoma offers an AI-powered Orchestration Platform

Medoma is a Swedish startup that develops an AI-powered orchestration platform to deliver hospital-grade acute care in patient homes.

The platform combines clinical workflows, real-time coordination, and patient engagement. It also has the following modules:

• Medoma Center is a command and control hub that uses AI-powered planning and capacity forecasts to optimize staffing and schedules.
• Medoma Care is a mobile-facing app that guides patients through care plans, connects them to caregivers, and allows remote health updates.
• Medoma Go is a field toolkit for caregivers. It provides scheduling, communication, and real-time information while treating patients at home.

Wisdom-io provides an Ambient Smart Home System

Wisdom-io is a US-based startup that builds an ambient smart home system for the elderly. It utilizes sensors to monitor movement and detect potential falls. It also learns daily behaviors and flags deviations that could signal health risks.

A speaker system also allows users to reach out to their network quickly. Further, families and caregivers stay connected via notifications, check-ins, and alerts when help is needed.

This way, the system allows caregivers and families to better track the elderly at home and ensure timely care delivery for them.

Discover all Medical Device Trends, Technologies & Startups

The principal focus of the medical device industry is to improve the health of the patient in a cost-effective manner. Thus, AI and robotics, along with wearables, will continue to grow for improved healthcare delivery.

The growth of the healthcare service sector will also accelerate software as a medical service (SaMD). With the increase in remote treatment capabilities and immersive technologies, the R&D of mental health rehabilitation devices would be at the forefront.

The Medical Device Trends & Startups outlined in this report only scratch the surface of trends that we identified during our data-driven innovation & startup scouting process. Identifying new opportunities & emerging technologies to implement into your business goes a long way in gaining a competitive advantage.